This links the increased miR-155 levels in CF epithelial cells to the progressive fibrosis of the CF lung, as RPTOR inhibition activates the transforming growth factor beta (TGFβ) pathway to induce fibrosis [136]. The gene discussed is TGFB1; the disease is cystic fibrosis.